PHILADELPHIA, Pennsylvania, Oct. 20 -- The University of Pennsylvania posted the following news:

* * *

Using AI, Reddit to identify potential side effects of unapproved new GLP-1

*

Retatrutide, a next-generation GLP-1 weight-loss drug, is not yet approved for use. Nevertheless, online forums reveal that people are purchasing unapproved versions of the drug, which are not intended for human consumption, and sharing their experiences.